The burning question: To use or not to use cyclophosphamide in systemic sclerosis by Cosimo Bruni, Daniel E. Furst

Get full text

Targeting inflammatory pathways in axial spondyloarthritis by Daniel E. Furst, James S. Louie

Get full text

Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed? by Cosimo Bruni, Tracy Frech, Mirko Manetti, Francesca Wanda Rossi, Daniel E. Furst, Daniel E. Furst, Daniel E. Furst, Amato De Paulis, Felice Rivellese, Serena Guiducci, Serena Guiducci, Marco Matucci-Cerinic, Marco Matucci-Cerinic, Silvia Bellando-Randone, Silvia Bellando-Randone

Get full text

Examination of the Validity of Skin Ultrasound to Quantitate Skin Involvement for Multicenter Clinical Trials in Patients with Systemic Sclerosis (SSc): A Systematic Literature Rev... by Omar M. Aly, Kevin L. Kafaja, Yossra A. Suliman, Daniel E. Furst

Get full text

Serum B-cell activating factor and lung ultrasound B-lines in connective tissue disease related interstitial lung disease by Yukai Wang, Xuezhen Xie, Shaoyu Zheng, Guangzhou Du, Shaoqi Chen, Weijin Zhang, Jinghua Zhuang, Jianqun Lin, Shijian Hu, Kedi Zheng, Angelina Mikish, Zhuangyong Xu, Guohong Zhang, Luna Gargani, Cosimo Bruni, Anna-Maria Hoffmann-Vold, Marco Matucci-Cerinic, Marco Matucci-Cerinic, Daniel E. Furst, Daniel E. Furst, Daniel E. Furst

Get full text

Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data by Paul Emery, Daniel E. Furst, Petra Kirchner, Simone Melega, Stuart Lacey, Patricia B. Lehane

Get full text

Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial by Roy Fleischmann, Daniel E. Furst, Erin Connolly-Strong, Jingyu Liu, Julie Zhu, Richard Brasington

Get full text

Agreements and Discrepancies between FDA Reports and Journal Papers on Biologic Agents Approved for Rheumatoid Arthritis: A Meta-Research Project. by Gil Amarilyo, Daniel E Furst, Jennifer M P Woo, Wen Li, Henning Bliddal, Robin Christensen, Simon Tarp

Get full text

What Matters in Psoriatic Arthritis: A Comparison of Patient and Clinician Perspectives by Philip J. Mease, M. Elaine Husni, Evan Siegel, Daniel E. Furst, Melissa Mcilraith, Vibeke Strand, M. Cameron Hay

Get full text

Most Trial Eligibility Criteria and Patient Baseline Characteristics Do Not Modify Treatment Effect in Trials Using Targeted Therapies for Rheumatoid Arthritis: A Meta-Epidemiologi... by Anton Wulf Christensen, Simon Tarp, Daniel E Furst, Anna Døssing, Kirstine Amris, Henning Bliddal, Peter C Taylor, Robin Christensen

Get full text

High-frequency ultrasound of the skin in systemic sclerosis: an exploratory study to examine correlation with disease activity and to define the minimally detectable difference by Hongyan Li, Daniel E. Furst, Hongtao Jin, Chao Sun, Xiaoping Wang, Lin Yang, Jingjing He, Yanru Wang, Aijing Liu

Get full text

Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials... by Andrea Rubbert-Roth, Daniel E. Furst, Stefano Fiore, Amy Praestgaard, Vivian Bykerk, Clifton O. Bingham, Christina Charles-Schoeman, Gerd Burmester

Get full text

Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study by Daniel E Furst, Paul Emery, Gerd R Burmester, Vivian P Bykerk, Bernard G Combe, Michael A Maldonado, Tom WJ Huizinga

Get full text

Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis by Philip J Mease, Daniel E Furst, Jeffrey R Lisse, Christophe Sapin, Kirstin Griffing, Sarah Ross, Paulo Reis, Aisha Vadhariya, Soumya Reddy

Get full text

Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II) by Dinesh Khanna, Philip J. Clements, Elizabeth R. Volkmann, Holly Wilhalme, Chi-hong Tseng, Daniel E. Furst, Michael D. Roth, Oliver Distler, Donald P. Tashkin

Get full text

Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung... by Elizabeth R. Volkmann, Donald P. Tashkin, Holly LeClair, Michael D. Roth, Grace Kim, Jonathan Goldin, Philip J. Clements, Daniel E. Furst, Dinesh Khanna

Get full text

Economic and Health Care Resource Use Burden of Systemic Sclerosis by Dinesh Khanna, Daniel E. Furst, Justin W. Li, Qian Meng, Yuan Yuan, Tamara Lesperance, Kenyatta Peoples, Farah Ali, Brian LaMoreaux, Stephanie D. Taylor

Get full text

A versatile role for lung ultrasound in systemic autoimmune rheumatic diseases related pulmonary involvement: a narrative review by Yukai Wang, Shaoqi Chen, Shaoyu Zheng, Zexuan Zhou, Weijin Zhang, Guangzhou Du, Angelina Mikish, Barbara Ruaro, Cosimo Bruni, Anna-Maria Hoffmann-Vold, Luna Gargani, Marco Matucci-Cerinic, Daniel E Furst

Get full text

Racial Disparities in Systemic Sclerosis: Short‐ and Long‐Term Outcomes Among African American Participants of SLS I and II by Elizabeth R. Volkmann, Virginia Steen, Ning Li, Michael D. Roth, Philip J. Clements, Daniel E. Furst, Shervin Assassi, Dinesh Khanna, Grace‐Hyun J. Kim, Jonathan Goldin, Robert M. Elashoff, Donald P. Tashkin

Get full text

Qualitative Interviews to Assess the Content Validity and Usability of the Electronic Raynaud Diary in Patients with Systemic Sclerosis by Robyn T. Domsic, Robin Pokrzywinski, Larissa Stassek, Wade W. Benton, Christa‐Lynn Vampola, Daniel E. Furst, Lorinda Chung, Virginia Steen, Maureen D. Mayes, Ami A. Shah, Jerry A. Molitor, Kelly Oliver, Vivek Nagaraja, Dinesh Khanna

Get full text